- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-106/15: Order of the General Court of 16 July 2015 — Opko Ireland Global Holdings v OHIM — Teva Pharmaceutical Industries (ALPHAREN) (Community trade mark — Opposition proceedings — Revocation of the contested decision by OHIM — No need to adjudicate)
ECLI:EU:UNKNOWN:62015TB0106
62015TB0106
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 328/9
(Case T-106/15)(1)
((Community trade mark - Opposition proceedings - Revocation of the contested decision by OHIM - No need to adjudicate))
(2015/C 328/07)
Language of the case: English
Parties
Applicant: Opko Ireland Global Holdings (Dublin, Ireland) (represented by: S. Malynicz, Barrister, and A. Smith, Solicitor)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Folliard-Monguiral, acting as Agent)
Other party to the proceedings before the Board of Appeal of OHIM intervening before the General Court: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: G Farrington, Solicitor)
Re:
Action brought against the decision of the Fifth Board of Appeal of OHIM of 26 November 2014 (Case R 2387/2014-5) relating to opposition proceedings between Teva Pharmaceutical Industries Ltd and Opko Ireland Global Holdings Ltd.
Operative part of the order
1.There is no need to adjudicate on the action.
2.The Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) shall bear all of the costs.
(1)
OJ C 228, 13.7.2015.